Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study - Romain Arrestier; Paul Bastard; Thibaut Belmondo; Guillaume Voiriot; Tomas Urbina; Charles-Edouard Luyt; Adrian Gervais; Lucy Bizien; Lauriane Segaux; Mariem Ben Ahmed; Raphaël Bellaïche; Taï Pham; et al. (Annals of Intensive Care, 2022)